No reported Insider Trades available for Glenmark Pharmaceuticals Ltd in the Trendlyne database.
Glenmark Pharmaceuticals Ltd's has made SAST transactions in Alivus Life Sciences Ltd. recently where a Pledge of 24,505,435 shares done . Disclosure was reported to the exchange on March 13, 2024.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Pledge | 24 Dec 2024 | 24,505,435 | 9,609,571 | 20% | - | 12 Mar 2024 12 Mar 2024 |
SAST (Reg31) | - | Release | |
| Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Disposal | 22 Jul 2024 | 9,609,571 | - | 7.84% | - | 11 Jul 2024 12 Jul 2024 |
SAST (29(2)) | - | Offer For Sale | |
| Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Non disposal undertaking | 17 Jul 2024 | 9,609,571 | 0 | - | - | 04 Jul 2024 04 Jul 2024 |
SAST (Reg31) | - | Release | |
| Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Disposal | 19 Mar 2024 | 24,505,435 | 9,609,571 (7.84%) | 20% | - | 12 Mar 2024 12 Mar 2024 |
SAST (29(2)) | - | Off Market | |
| Alivus Life Sciences | Glenmark Pharmaceuticals Ltd | Promoter | Disposal | 14 Mar 2024 | 67,389,944 | 34,115,006 (27.84%) | 55% | - | 06 Mar 2024 06 Mar 2024 |
SAST (29(2)) | - | Off Market |